How Syros Pharmaceuticals Uses Nasdaq Rule 5635©(4) to Incentivize New Hires
Syros Pharmaceuticals, a biopharmaceutical company that develops new treatments for hematologic malignancies, announced that it has granted restricted stock unit (RSU) awards to three new employees as part of their compensation package. The RSUs were granted in accordance with Nasdaq Listing Rule 5635© (4), which allows companies to issue equity awards to new hires without …
How Syros Pharmaceuticals Uses Nasdaq Rule 5635©(4) to Incentivize New Hires Read More »